Youwei Xu

6.0k total citations
119 papers, 4.4k citations indexed

About

Youwei Xu is a scholar working on Molecular Biology, Pharmacology and Epidemiology. According to data from OpenAlex, Youwei Xu has authored 119 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 22 papers in Pharmacology and 18 papers in Epidemiology. Recurrent topics in Youwei Xu's work include Phytochemical Studies and Bioactivities (20 papers), Natural product bioactivities and synthesis (17 papers) and Liver Disease Diagnosis and Treatment (16 papers). Youwei Xu is often cited by papers focused on Phytochemical Studies and Bioactivities (20 papers), Natural product bioactivities and synthesis (17 papers) and Liver Disease Diagnosis and Treatment (16 papers). Youwei Xu collaborates with scholars based in China, United States and Germany. Youwei Xu's co-authors include Yan Qi, Jinyong Peng, Lina Xu, Lianhong Yin, Xu Han, Kexin Liu, Xu Han, Xufeng Tao, Lingli Zheng and Changyuan Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Youwei Xu

114 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youwei Xu China 43 2.4k 631 533 451 406 119 4.4k
Sang Kyum Kim South Korea 39 2.2k 0.9× 766 1.2× 397 0.7× 377 0.8× 226 0.6× 225 4.9k
Jingyuan Wan China 38 1.3k 0.5× 636 1.0× 430 0.8× 350 0.8× 502 1.2× 112 3.5k
Yan Qi China 50 3.3k 1.4× 721 1.1× 784 1.5× 487 1.1× 563 1.4× 208 6.3k
Lina Xu China 48 3.3k 1.4× 845 1.3× 876 1.6× 597 1.3× 519 1.3× 162 6.2k
Lili Ding China 40 2.0k 0.8× 436 0.7× 632 1.2× 272 0.6× 430 1.1× 151 4.9k
Yue Dai China 43 2.3k 1.0× 704 1.1× 400 0.8× 432 1.0× 706 1.7× 185 5.2k
Amr Amin United Arab Emirates 47 1.9k 0.8× 851 1.3× 442 0.8× 837 1.9× 216 0.5× 159 5.3k
Alexandra K. Kiemer Germany 42 2.0k 0.8× 363 0.6× 474 0.9× 263 0.6× 834 2.1× 137 4.6k
Jinhui Wang China 32 2.2k 0.9× 440 0.7× 254 0.5× 702 1.6× 284 0.7× 251 4.0k
Vincent Kam Wai Wong Macao 39 2.5k 1.0× 403 0.6× 781 1.5× 247 0.5× 335 0.8× 183 4.5k

Countries citing papers authored by Youwei Xu

Since Specialization
Citations

This map shows the geographic impact of Youwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youwei Xu more than expected).

Fields of papers citing papers by Youwei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youwei Xu. The network helps show where Youwei Xu may publish in the future.

Co-authorship network of co-authors of Youwei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Youwei Xu. A scholar is included among the top collaborators of Youwei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youwei Xu. Youwei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Hongli, Chongzhao You, Yixiao Zhang, et al.. (2025). Structural insights into antagonist recognition by the vasopressin V2 receptor. Nature Communications. 16(1). 9734–9734.
2.
Meng, Xue, Yang Li, Kai Wu, et al.. (2025). Structural insights into the activation of the human prostaglandin E 2 receptor EP1 subtype by prostaglandin E 2. Proceedings of the National Academy of Sciences. 122(20). e2423840122–e2423840122. 2 indexed citations
3.
You, Chongzhao, Shimeng Guo, Xinheng He, et al.. (2025). Molecular mechanism of pH sensing and activation in GPR4 reveals proton-mediated GPCR signaling. Cell Discovery. 11(1). 59–59. 1 indexed citations
4.
Wu, Canrong, Yong Zhang, Antao Dai, et al.. (2025). Molecular mechanisms of urate transport by the native human URAT1 and its inhibition by anti-gout drugs. Cell Discovery. 11(1). 33–33. 2 indexed citations
5.
Ding, Yanfang, Jingjing Qi, Peng Chu, et al.. (2025). Cascade-responsive nanoplatform for synergistic cancer therapy via ROS amplification and hypoxia targeting. Chemical Engineering Journal. 516. 164112–164112. 1 indexed citations
6.
Xu, Youwei, Wen Hu, Yi Jiang, et al.. (2024). Molecular recognition and activation of the prostacyclin receptor by anti-pulmonary arterial hypertension drugs. Science Advances. 10(6). eadk5184–eadk5184. 7 indexed citations
7.
Xu, Youwei, Li Hou, Xinheng He, et al.. (2024). Molecular basis of lipid and ligand regulation of prostaglandin receptor DP2. Proceedings of the National Academy of Sciences. 121(51). e2403304121–e2403304121. 5 indexed citations
8.
Cai, Hongmin, Shimeng Guo, Youwei Xu, et al.. (2024). Cryo-EM structures of adenosine receptor A3AR bound to selective agonists. Nature Communications. 15(1). 3252–3252. 25 indexed citations
9.
Wang, Yue, Weiyi Liu, Youwei Xu, et al.. (2023). Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins. Nature Chemical Biology. 19(11). 1351–1360. 36 indexed citations
10.
You, Chongzhao, Youwei Xu, Peiyu Xu, et al.. (2023). Structural basis for motilin and erythromycin recognition by motilin receptor. Science Advances. 9(11). eade9020–eade9020. 12 indexed citations
11.
Chen, Yan, Qingtong Zhou, Jiang Wang, et al.. (2023). Ligand recognition mechanism of the human relaxin family peptide receptor 4 (RXFP4). Nature Communications. 14(1). 492–492. 7 indexed citations
12.
Duan, Jia, Qiufeng Liu, Qingning Yuan, et al.. (2022). Insights into divalent cation regulation and G13-coupling of orphan receptor GPR35. Cell Discovery. 8(1). 135–135. 31 indexed citations
13.
Su, Jie, Qiaoshuai Lan, Yu Zhou, et al.. (2022). Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein. Communications Biology. 5(1). 1179–1179. 5 indexed citations
14.
Zhang, Yimeng, Xufeng Tao, Lianhong Yin, et al.. (2017). Protective effects of dioscin against cisplatin‐induced nephrotoxicity via the microRNA‐34a/sirtuin 1 signalling pathway. British Journal of Pharmacology. 174(15). 2512–2527. 87 indexed citations
15.
Zheng, Lingli, Lianhong Yin, Lina Xu, et al.. (2017). Protective effect of dioscin against thioacetamide-induced acute liver injury via FXR/AMPK signaling pathway in vivo. Biomedicine & Pharmacotherapy. 97. 481–488. 51 indexed citations
16.
Si, Lingling, Lingli Zheng, Lina Xu, et al.. (2016). Dioscin suppresses human laryngeal cancer cells growth via induction of cell-cycle arrest and MAPK-mediated mitochondrial-derived apoptosis and inhibition of tumor invasion. European Journal of Pharmacology. 774. 105–117. 56 indexed citations
17.
Zhang, Weixin, Lianhong Yin, Xufeng Tao, et al.. (2016). Dioscin alleviates dimethylnitrosamine-induced acute liver injury through regulating apoptosis, oxidative stress and inflammation. Environmental Toxicology and Pharmacology. 45. 193–201. 46 indexed citations
18.
Liu, Min, Youwei Xu, Xu Han, et al.. (2015). Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF-κB signaling pathway. Scientific Reports. 5(1). 18038–18038. 103 indexed citations
19.
Dong, Deshi, Shuai Zhang, Lianhong Yin, et al.. (2013). Protective effects of the total saponins from Rosa laevigata Michx fruit against carbon tetrachloride-induced acute liver injury in mice. Food and Chemical Toxicology. 62. 120–130. 55 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sang Kyum Kim Breakdown of academic impact, for papers by Jingyuan Wan Breakdown of academic impact, for papers by Yan Qi Breakdown of academic impact, for papers by Lina Xu Breakdown of academic impact, for papers by Lili Ding Breakdown of academic impact, for papers by Yue Dai Breakdown of academic impact, for papers by Amr Amin Breakdown of academic impact, for papers by Alexandra K. Kiemer Breakdown of academic impact, for papers by Jinhui Wang Breakdown of academic impact, for papers by Vincent Kam Wai Wong
Rankless by CCL
2026